Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Leukemia & Lymphoma|October 31, 2006
NY-ESO-1 immunotherapy for multiple myelomaSusann Szmania, Guido Tricot, Frits van RheeBlood and Lymphatic Cancer : Targets and Therapy|May 26, 2015
Profile of elotuzumab and its potential in the treatment of multiple myelomaYi-Chang Liu, Susann Szmania, Frits van RheeClinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.British Journal of Haematology|July 13, 2010
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patientsQing Yi, Susann Szmania, John Freeman, et al.Cytotherapy|December 22, 2010
Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103Amberly Moreno-Bost, Susann Szmania, Katie Stone, et al.Vaccine|January 11, 2014
Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vectorRamesh B Batchu, Oksana V Gruzdyn, Amberly M Moreno-Bost, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myelomaSusann Szmania, Sacha Gnjatic, Guido Tricot, et al.British Journal of Haematology|October 28, 2008
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantationJumei Shi, Guido Tricot, Susann Szmania, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.Cytotherapy|August 21, 2012
Large-scale ex vivo expansion and characterization of natural killer cells for clinical applicationsNatalia Lapteva, April G Durett, Jiali Sun, et al.Pageof 2